ACEIs and ARBs and Their Correlation with COVID-19: A Review

被引：20

作者：

Shewasinad Yehualashet, Awgichew ^{[1
]}

Fentik Belachew, Teshome ^{[2
]}

机构：

[1] Debre Berhan Univ, Dept Pharm, Coll Hlth Sci, Pharmacol & Toxicol Unit, POB 445, Debre Berhan, Ethiopia

[2] Debre Birhan Hlth Sci Coll, Dept Pharm, Debre Birhan, Ethiopia

来源：

INFECTION AND DRUG RESISTANCE | 2020年 / 13卷

关键词：

coronavirus; COVID-19; ACEIs; ARBs; RENIN-ANGIOTENSIN SYSTEM; CONVERTING ENZYME 2; RECEPTOR BLOCKERS; CORONAVIRUS; INHIBITORS; METAANALYSIS; THERAPY; TMPRSS2; SARS;

D O I：

10.2147/IDR.S264882

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Although some animal studies suggested that the use of ACEIs/ARBs could contribute for the prevention and treatment of the effects of the COVID-19 infection, there are also contradictory scenarios indicating that their use may exacerbate the deleterious conditions of the infection. As a result of the paradoxical issue of using ACEIs/ARBs during COVID-19, it is still an area requiring extended investigation to prove. Additionally, a trial evidence of their efficacy and the possible benefit risk analysis of these conventional drugs during COVID-19 in connection with other comorbidities like hypertension, heart failure, and renal disease associated with diabetes should also be addressed.

引用

页码：3217 / 3224

页数：8

共 50 条

[31] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
Narges Najafi
Alireza Davoudi
Hamideh Izadyar
Abbas Alishahi
Armaghan Mokhtariani
Bahareh Soleimanpourian
Mina Tabarrayi
Mahmood Moosazadeh
Zahra Daftarian
Fatemeh Ahangarkani
Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1517 - 1523
[32] Effect of the Baseline Use of Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin-Receptor Blockers (ARBs) on Outcomes of Patients With Suspected or Positive COVID-19 Infection
Muhlestein, Joseph B.
Knowlton, Kirk U.
May, Heidi T.
Knight, Stacey
Bair, Tami L.
Le, Viet T.
Horne, Benjamin D.
Anderson, Jeffrey L.
CIRCULATION, 2020, 142
[33] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
Najafi, Narges
Davoudi, Alireza
Izadyar, Hamideh
Alishahi, Abbas
Mokhtariani, Armaghan
Soleimanpourian, Bahareh
Tabarrayi, Mina
Moosazadeh, Mahmood
Daftarian, Zahra
Ahangarkani, Fatemeh
IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1517 - 1523
[34] From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Matsoukas, John
Apostolopoulos, Vasso
Zulli, Anthony
Moore, Graham
Kelaidonis, Konstantinos
Moschovou, Kalliopi
Mavromoustakos, Thomas
MOLECULES, 2021, 26 (03):
[35] Anticancer Potential of ACEIs/ARBs Administration in Colorectal Cancer
Wang, Xin
Jing, Haiyun
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (30) : 4867 - 4879
[36] Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review
Caramaschi, Stefania
Kapp, Meghan E.
Miller, Sara E.
Eisenberg, Rosana
Johnson, Joyce
Epperly, Garretson
Maiorana, Antonino
Silvestri, Guido
Giannico, Giovanna A.
MODERN PATHOLOGY, 2021, 34 (09) : 1614 - 1633
[37] THE CORRELATION BETWEEN PSYCHIATRIC DISORDERS AND COVID-19: A NARRATIVE REVIEW
He, Yanfei
Yu, Ran
Ren, Junlin
PSYCHIATRIA DANUBINA, 2021, 33 (01) : 76 - 85
[38] Correlation between COVID-19 and hepatitis B: A systematic review
He, Yan-Fei
Jiang, Zhi-Gang
Wu, Ni
Bian, Ning
Ren, Jun-Lin
WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (46) : 6599 - 6618
[39] Correlation between COVID-19 and hepatitis B: A systematic review
Yan-Fei He
Zhi-Gang Jiang
Ni Wu
Ning Bian
Jun-Lin Ren
World Journal of Gastroenterology, 2022, 28 (46) : 6599 - 6618
[40] COVID-19 Review
Reichardt, Alina
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (29-30):

← 1 2 3 4 5 →